Why approval of KarXT, the first new drug for schizophrenia in decades, is a big deal

After more than three decades, schizophrenia patients have a new treatment option. The US FDA has approved a drug, known as KarXT or Cobenfy. It comes without common side effects such as weight gain and movement disorders found in other drugs